scholarly journals Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trial

2016 ◽  
Vol 27 ◽  
pp. vi564 ◽  
Author(s):  
J. Bruix ◽  
P. Merle ◽  
A. Granito ◽  
Y.-H. Huang ◽  
G. Bodoky ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Health Related Quality ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Health ◽  
Related Quality ◽  
Health Related

scholarly journals Health-Related Quality of Life as Measured by the 36-item Short Form Survey Among Adults with Acute Bacterial Skin and Skin Structure Infections Who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial

2021 ◽  
Author(s):  
Surya Chitra ◽  
Jordan Hinahara ◽  
Thomas F Goss ◽  
Kyle Gunter ◽  
Kenneth LaPensee
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Oral Treatment ◽  
Health Related Quality ◽  
Phase 3 ◽  
Double Blind ◽  
Skin Structure ◽  
Related Quality ◽  
Health Related

Abstract This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n=368) or linezolid (n=367) was associated with improvement in health-related quality of life.

Predictors of Health-Related Quality of Life in Hepatocellular Carcinoma

2009 ◽  
Author(s):  
Leigh A. Gemmell ◽  
T. Clark Gamblin ◽  
Jennifer M. Hammond ◽  
Sonja Likumahuwa ◽  
Richard Schulz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related
Sign in / Sign up

Export Citation Format

Share Document